Calendar Perspective Therapeutics, Inc.

Equities

CATX

US46489V3024

Market Closed - Nyse 21:00:00 19/07/2024 BST 5-day change 1st Jan Change
12.64 USD +6.31% Intraday chart for Perspective Therapeutics, Inc. -2.09% +214.43%

Chart calendar Perspective Therapeutics, Inc.

0b84410adb29c7b6.7wckGbepUUgXqHSL0Bd1a6_pS5rEcbAZ_FR7ikCJvRM.nGhjbdDFGCZQ3hvPkiYFOeaTKcOdCIErkQM03AK61FGWXUhK4f4-MkTnOQ~0173067d71c8fa0fdaf56adefd67c254

Upcoming events on Perspective Therapeutics, Inc.

08/08/2024 Q2 2024 Earnings Release (Projected)
11/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Perspective Therapeutics, Inc.

16/06/2024 Reverse Split: 1 of 10
11/06/2024 13:30 Society of Nuclear Medicine & Molecular Imaging Meeting - Abstract No - 242110
10/06/2024 18:40 Society of Nuclear Medicine & Molecular Imaging Meeting - Abstract No - 242556
10/06/2024 15:00 Society of Nuclear Medicine & Molecular Imaging Meeting - Abstract No - 242347
10/06/2024 15:00 Society of Nuclear Medicine & Molecular Imaging Meeting - Abstract No - 242430
09/06/2024 23:30 Society of Nuclear Medicine & Molecular Imaging Meeting - Abstract No - 241509
08/06/2024 19:55 Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No - 241158
31/05/2024 17:00 Annual General Meeting
22/05/2024 16:00 William Blair Radiopharma Conference
19/05/2024 Cantor Frontiers in Radiopharma Virtual Summit
15/05/2024 18:00 BofA Securities Health Care Conference
15/05/2024 14:30 RBC Capital Markets Global Healthcare Conference
15/05/2024 12:00 Q1 2024 Earnings Release
13/05/2024 19:00 Guggenheim Securities Radiopharmaceuticals Day - Panel
11/04/2024 13:35 Jefferies Radiopharma Innovation Summit
09/04/2024 19:40 Goldman Sachs Third Annual Healthruption Conference
28/03/2024 11:30 Q4 2023 Earnings Release
18/03/2024 14:00 Analyst Day
01/03/2024 19:30 B. Riley Securities Radiopharma Day - Panel
01/03/2024 18:45 B. Riley Securities Radiopharma Day - Panel

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
7,31
7,41
-1.35%
9,68
10,1
-4.08%
10,1
10,0
0.2%
3,55


1,43
8,46
-83.04%

0,49

EBITDA
Million USD
Released
Forecast
Spread
-5,07
-5,10
0.63%
-2,87
-3,10
7.45%
-2,87
-2,80
-2.64%
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-5,25
-5,62
6.45%
-3,55
-3,40
-4.28%
-3,45
-3,29
-4.62%
0,00


-40,9
-43,4
5.6%

-55,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-5,14
-5,53
6.92%
-3,45
-3,39
-1.77%
-3,39
-3,30
-2.64%
0,00


-40,1
-43,0
6.64%

-53,3

Net income
Million USD
Released
Forecast
Spread
-5,16
-5,53
6.72%
-3,46
-3,39
-2.1%
-3,39
-3,25
-4.3%
0,00


-46,5
-37,7
-23.33%

-53,3

EPS
USD
Released
Forecast
Spread
-0,80
-0,85
5.88%
-0,50
-0,45
-11.11%
-0,30
-0,27
-12.5%
-0,50


-1,70
-1,40
-21.43%

-0,68

Announcement Date24/09/1917/09/2021/09/2101/05/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
2,06


2,09
2,61
-20%
1,91
2,20
-13.23%
-4,90
2,12
-331.06%
0,33
0,07
372.38%

0,06


0,06


0,06


0,11


0,00

EBIT
Million USD
Released
Forecast
Spread



-11,4
-7,66
-48.56%
-10,5
-10,3
-2.57%
-7,81
-10,2
23.79%
-13,0
-12,7
-2.55%

-13,8


-14,2


-14,7


-15,2


-15,6

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



-11,1
-7,65
-45.21%
-10,4
-10,3
-0.92%
-7,77
-10,7
27.11%
-12,3
-11,7
-5.28%

-13,3


-13,6


-14,2


-15,2


-15,6

Net income
Million USD
Released
Forecast
Spread



-11,1
-7,65
-45.16%
-10,4
-10,3
-0.89%
-24,7
-10,7
-131.35%
-12,3
-12,6
2.72%

-13,3


-13,6


-14,2


-15,2


-15,6

EPS
USD
Released
Forecast
Spread
0,00


-0,40
-0,30
-33.33%
-0,40
-0,40
0%
-0,90
-0,40
-125%
-0,20
-0,28
28.57%

-0,15


-0,15


-0,15


-0,23


-0,24

Announcement Date15/05/2311/08/2314/11/2328/03/2415/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CATX Stock
  4. Calendar Perspective Therapeutics, Inc.